Bayer receives first approval for Lynkuet in UK as treatment for vasomotor symptoms associated with menopause
The UK authorization is based on positive results from the Phase III OASIS-1, -2, and -3 trials
The UK authorization is based on positive results from the Phase III OASIS-1, -2, and -3 trials
Insights are drawn from over 30K+ people across 300+ cities including all metro and tier-1 cities
The pharmaceuticals laboratory supports North Asia with formulation development, reverse engineering, troubleshooting, and analysis for various dosage forms
India’s fertility rate has dropped to 1.9, below the replacement level of 2.1
He has held senior leadership positions at Syngene International, Fujifilm Diosynth Biotechnologies, Thermo Fisher Scientific, Sartorius Stedim Biotech, and other leading organizations
CSIR-IGIB advances indigenous CRISPR Trials on sickle cell anaemia, anti-microbial resistance, liver fibrosis and rare disorders
Vevzuo is authorized for the prevention of skeletal related events in adults with advanced malignancies involving bone
The audit has been concluded with no major observations
Subscribe To Our Newsletter & Stay Updated